menu
    • menu

    Company profile for Praxis Precision Medicines

    NEW Drugs in Dev: 9
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders. At Praxis we get things done. Praxis is the process of using a theory or something that you have learned in a practical way. It is a mindset that allows us to simplify the complex and independently define a solution without being restricted by predefined pro...
    Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders. At Praxis we get things done. Praxis is the process of using a theory or something that you have learned in a practical way. It is a mindset that allows us to simplify the complex and independently define a solution without being restricted by predefined processes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Praxis Precision MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Broadway, 16th Floor, Cambridge, MA 02142
    Telephone
    Telephone
    617-300-8460
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://praxismedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/praxis-precision-medicines-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Praxis Precision Medicines Announces Inducement Grants
    Praxis Precision Medicines Announces Inducement Grants

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267813/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Praxis Precision Gets FDA Priority Review for Relutrigine in DEEs
    Praxis Precision Gets FDA Priority Review for Relutrigine in DEEs

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264996/0/en/Praxis-Precision-Medicines-Announces-FDA-Acceptance-and-Priority-Review-of-New-Drug-Application-for-Relutrigine-in-Patients-with-SCN2A-and-SCN8A-DEEs.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Praxis Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    Praxis Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249717/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Praxis Precision Medicines Updates Corporate Progress
    Praxis Precision Medicines Updates Corporate Progress

    19 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/19/3240986/0/en/Praxis-Precision-Medicines-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    19 Feb 2026
    Share Share
    Praxis Precision Medicines To Release Q4 2025 Financials, Join
    Praxis Precision Medicines To Release Q4 2025 Financials, Join

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234882/0/en/Praxis-Precision-Medicines-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Thursday-February-19-2026-and-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Praxis Precision Announces Inducement Grants Under Nasdaq LR
    Praxis Precision Announces Inducement Grants Under Nasdaq LR

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3232451/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search